tykhr
sign in
free sign up
Transcode Therapeutics Inc
Biotechnology
Healthcare
RNAZ
834 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
10.80
52 week high
32.34
high
10.98
52 week low
0.00
low
10.36
growth
-9.67 %
previous Close
11.38
P/E ratio
-2
market cap
8.17 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-4.28 M
64.61 %
eps
-5.13 %
92.69 %
eps surprise
0.00 %
net profit margin
-427650200.00 %
0.00 %
operating incoming
-4.07 M
-28.27 %
net change in cash
-4.19 M
-172.84 %
cash on hand
7.37 M
-36.25 %
cost of revenue
0.00 %
top